Issue 29, 2015

Effective delivery of a rationally designed intracellular peptide drug with gold nanoparticle–peptide hybrids

Abstract

A novel gold nanoparticle–peptide hybrid strategy was developed to intracellularly deliver a potent PKCδ inhibitor peptide for the treatment of acute lung injury. The gold nanoparticle–peptide hybrids showed good stability with high uptake, and demonstrated in vitro and in vivo efficacy. Our formulation strategy shows great promise in intracellular delivery of peptides.

Graphical abstract: Effective delivery of a rationally designed intracellular peptide drug with gold nanoparticle–peptide hybrids

Supplementary files

Article information

Article type
Communication
Submitted
13 Apr 2015
Accepted
25 Jun 2015
First published
07 Jul 2015

Nanoscale, 2015,7, 12356-12360

Author version available

Effective delivery of a rationally designed intracellular peptide drug with gold nanoparticle–peptide hybrids

D. Lee, J. Zhao, H. Yang, S. Xu, H. Kim, S. Pacheco, S. Keshavjee and M. Liu, Nanoscale, 2015, 7, 12356 DOI: 10.1039/C5NR02377G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements